Reports
Sale
North America Balloon Catheters Market Size, Share, Growth: By Product Type: PTA Balloon Catheters, PTCA Balloon Catheters, Occlusion Balloon Catheters, Foley Catheters, Nephrostomy Balloon Catheters, Others; By Catheter Type; By Balloon Type; By Material; By Indication; By End User; Regional Analysis; Supplier Landscape; 2024-2032
North America Balloon Catheters Market Outlook
The North America balloon catheters market size was valued at USD 1.3 billion in 2023. It is expected to grow at a CAGR of 10.59% during the forecast period of 2024-2032, driven by the rising prevalence of cardiovascular diseases in the region. The market is estimated to reach a value of USD 3.3 billion by 2032.
Key Takeaways
- In December 2023 , the United States Food and Drug Administration (FDA) approved Summa Therapeutics’ Finesse Injectable angioplasty balloon catheters for the treatment of peripheral artery disease.
- In December 2023 , an Exclusive Commercial Agreement was signed between HR Pharmaceuticals, Inc. (HRP) and Poiesis Medical LLC, which granted HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America.
- In the United States , heart disease is the leading cause of mortality, with Centers for Disease Control and Prevention data reporting that one individual dies every 33 seconds from cardiovascular disease.
Balloon catheters have an inflatable balloon at the tip, which can enlarge a narrow opening in a catheterization procedure. The minimally invasive nature of the device is attracting high demand in the market for various medical interventions such as angioplasty and stenting. With a rising patient inclination towards minimally invasive procedures due to certain benefits including reduced surgical trauma and shortened recovery time, North America balloon catheters market demand is expected to witness a surge in the forecast period.
The market is experiencing improvement in the regulatory landscape which boosts the growth. Faster regulatory approvals not only enhance access to novel balloon catheter products but also increase their adoption rates in the healthcare sector. In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC (a United States-based medical devices company), for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease. The Finesse product line includes a port for injecting radiopaque contrast material coupled with its performance of balloon angioplasty, making it an advanced toolset for angioplasty procedures. The availability of such innovative products in healthcare settings is anticipated to propel North America balloon catheters market share in the forecast period.
In December 2023 , an Exclusive Commercial Agreement was signed between a medical equipment manufacturer in the United States, HR Pharmaceuticals, Inc. (HRP), and Poiesis Medical LLC (a medical device company in Florida). As per the terms of collaboration, HRP received the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. This Dual Balloon Catheter technology is designed for patients enduring prolonged catheterization and exhibits better results as compared to traditional Foley Catheters. The increased access to such innovative balloon catheter products to the rising patient population in the region is likely to fuel market growth. The rise in strategic partnerships among the key market players which support the market expansion of balloon catheter devices marks as one of the most significant North America balloon catheters market trends.
Other factors that drive the market value include the presence of advanced infrastructure. The growing elderly population more prone to cardiovascular diseases is also poised to directly affect the market demand. Further, the existence of several leading market players and premium research institutions positively impacts the market landscape.
North America Balloon Catheters Market Segmentation
“North America Balloon Catheters Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product Type | PTA Balloon Catheters, PTCA Balloon Catheters, Occlusion Balloon Catheters, Foley Catheters, Nephrostomy Balloon Catheters, Drug-Eluting Catheters, Normal Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Drug Eluting Balloon Catheter, Stent Graft Balloon Catheter, Others |
| Catheter Type | Fixed Wire, Over-The-Wire, Rapid Exchange |
| Balloon Type | Non-Compliant, Semi-Compliant, Compliant |
| Material | Polyurethane, Nylon, Others |
| Indication | Coronary Artery Disease, Peripheral Vascular Disease |
| End User | Hospitals, Specialty Clinics, Others |
| Countries | United States of America, Canada |
North America Balloon Catheters Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic, Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Catheter Type |
|
| Breakup by Balloon Type |
|
| Breakup by Material |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Balloon Catheters Market Overview
3.1 North America Balloon Catheters Market Historical Value (2017-2023)
3.2 North America Balloon Catheters Market Forecast Value (2024-2032)
4 North America Balloon Catheters Market Landscape*
4.1 North America Balloon Catheters: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Balloon Catheters: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Catheters Type
4.2.3 Analysis by Balloon Type
5 North America Balloon Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Balloon Catheters Market Segmentation (2017-2032)
6.1 North America Balloon Catheters Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 PTA Balloon Catheters
6.1.3 PTCA Balloon Catheters
6.1.4 Occlusion Balloon Catheters
6.1.5 Foley Catheters
6.1.6 Nephrostomy Balloon Catheters
6.1.7 Drug -Eluting Catheters
6.1.8 Normal Balloon Catheter
6.1.9 Cutting Balloon Catheter
6.1.10 Scoring Balloon Catheter
6.1.11 Drug Eluting Balloon Catheter
6.1.12 Stent Graft Balloon Catheter
6.1.13 Others
6.2 North America Balloon Catheters Market (2017-2032) by Catheter Type
6.2.1 Market Overview
6.2.2 Fixed Wire
6.2.3 Over -The -Wire
6.2.4 Rapid Exchange
6.3 North America Balloon Catheters Market (2017-2032) by Balloon Type
6.3.1 Market Overview
6.3.2 Non-Compliant
6.3.3 Semi-Compliant
6.3.4 Compliant
6.4 North America Balloon Catheters Market (2017-2032) by Material
6.4.1 Market Overview
6.4.2 Polyurethane
6.4.3 Nylon
6.4.4 Others
6.5 North America Balloon Catheters Market (2017-2032) by Indication
6.5.1 Market Overview
6.5.2 Coronary Artery Disease
6.5.3 Peripheral Vascular Disease
6.6 North America Balloon Catheters Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Specialty Clinics
6.6.4 Others
6.7 North America Balloon Catheters Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United States of America
6.7.3 Canada
7 United States of America Balloon Catheters Market (2017-2032)
7.1 United States of America Balloon Catheters Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 PTA Balloon Catheters
7.1.3 PTCA Balloon Catheters
7.1.4 Occlusion Balloon Catheters
7.1.5 Foley Catheters
7.1.6 Nephrostomy Balloon Catheters
7.1.7 Drug -Eluting Catheters
7.1.8 Normal Balloon Catheter
7.1.9 Cutting Balloon Catheter
7.1.10 Scoring Balloon Catheter
7.1.11 Drug Eluting Balloon Catheter
7.1.12 Stent Graft Balloon Catheter
7.1.13 Others
7.2 United State of America Balloon Catheters Market (2017-2032) by Catheter Type
7.2.1 Market Overview
7.2.2 Fixed Wire
7.2.3 Over -The -Wire
7.2.4 Rapid Exchange
7.3 United State of America Balloon Catheters Market (2017-2032) by Balloon Type
7.3.1 Market Overview
7.3.2 Non-Compliant
7.3.3 Semi-Compliant
7.3.4 Compliant
7.4 United States of America Balloon Catheters Market (2017-2032) by Material
7.4.1 Market Overview
7.4.2 Polyurethane
7.4.3 Nylon
7.4.4 Others
7.5 United State of America Balloon Catheters Market (2017-2032) by Indication
7.5.1 Market Overview
7.5.2 Coronary Artery Disease
7.5.3 Peripheral Vascular Disease
7.6 United State of America Balloon Catheters Market (2017-2032) by End User
7.6.1 Market Overview
7.6.2 Hospitals
7.6.3 Specialty Clinics
7.6.4 Others
8 Canada Ballon Catheters Market (2017-2032)
8.1 Canada Balloon Catheters Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 PTA Balloon Catheters
8.1.3 PTCA Balloon Catheters
8.1.4 Occlusion Balloon Catheters
8.1.5 Foley Catheters
8.1.6 Nephrostomy Balloon Catheters
8.1.7 Drug -Eluting Catheters
8.1.8 Normal Balloon Catheter
8.1.9 Cutting Balloon Catheter
8.1.10 Scoring Balloon Catheter
8.1.11 Drug Eluting Balloon Catheter
8.1.12 Stent Graft Balloon Catheter
8.1.13 Others
8.2 Canada Balloon Catheters Market (2017-2032) by Catheter Type
8.2.1 Market Overview
8.2.2 Fixed Wire
8.2.3 Over -The -Wire
8.2.4 Rapid Exchange
8.3 Canada Balloon Catheters Market (2017-2032) by Balloon Type
8.3.1 Market Overview
8.3.2 Non-Compliant
8.3.3 Semi-Compliant
8.3.4 Compliant
8.4 Canada Balloon Catheters Market (2017-2032) by Material
8.4.1 Market Overview
8.4.2 Polyurethane
8.4.3 Nylon
8.4.4 Others
8.5 Canada Balloon Catheters Market (2017-2032) by Indication
8.5.1 Market Overview
8.5.2 Coronary Artery Disease
8.5.3 Peripheral Vascular Disease
8.6 Canada Balloon Catheters Market (2017-2032) by End User
8.6.1 Market Overview
8.6.2 Hospitals
8.6.3 Specialty Clinics
8.6.4 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Abbott Laboratories
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Becton Dickinson and Company
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Boston Scientific Corporation
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Bard Medical Division
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 B.Braun Melsungen AG
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Johnson & Johnson
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Teleflex Incorporated
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Medtronic, Plc.
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Edwards Lifesciences Corporation
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Vascular Solutions, Inc.
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 United States of America Cannula Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocketn
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 1.3 billion in 2023 driven by driven by the rising prevalence of cardiovascular diseases in the region.
The market is anticipated to grow at a CAGR of 10.59% during the forecast period of 2024-2032, likely to reach a market value of USD 3.3 billion by 2032.
Advancements in balloon catheter technology and rising healthcare expenditure are fuelling the demand for the regional market.
One of the significant trends in the market is the rise in strategic partnerships among the key market players. In December 2023, HR Pharmaceuticals, Inc. (HRP) and Poiesis Medical LLC, signed an exclusive commercial agreement which granted HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America.
Based on the product type, the market is segmented into PTA balloon catheters, PTCA balloon catheters, occlusion balloon catheters, foley catheters, nephrostomy balloon catheters, drug-eluting catheters, normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, and stent graft balloon catheter, among others.
Based on the product type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.
Major end users include hospitals and specialty clinics, among others.
Based on the material, the market includes polyurethane, and nylon, among others.
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
The market segmentation by countries includes the United States of America and Canada.
The key market players are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic PLC, Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER